Management of bowel obstruction in advanced and terminal cancer patients

C. Ripamonti, F. De Conno, V. Ventafridda, B. Rossi, M. J. Baines

Research output: Contribution to journalArticle

79 Citations (Scopus)

Abstract

Background: Bowel obstruction is a common and distressing outcome in patients with abdominal or pelvic cancer. Patients and methods: Patients may develop bowel obstruction at any time in their clinical history, with an incidence ranging from 5.5% to 42% in ovarian carcinoma and from 10% to 28.4% in colorectal cancer. The causes of the obstruction may be benign postoperative adhesions, a focal malignant or benign deposit, relapse or diffuse carcinomatosis. The symptoms which are almost always present are intestinal colic (reported in 72%-76% of patients), abdominal pain due to distension, hepatomegaly or tumor masses (in 92% of patients) and vomiting (68%-100%) of cases. Conclusion: While surgery must remain the primary treatment for malignant obstruction, it is now recognised that there is a group of patients with advanced disease or poor general condition who are unfit for surgery and require alternative management to relieve distressing symptoms. A number of treatment options are now available for the patient with advanced cancer who develops intestinal obstruction. In this review of the literature, the indications for surgery will be examined, the use of nasogastric tube and percutaneous gastrostomy evaluated and the place of drugs for symptom control described.

Original languageEnglish
Pages (from-to)15-21
Number of pages7
JournalAnnals of Oncology
Volume4
Issue number1
Publication statusPublished - 1993

Fingerprint

Obstruction
Surgery
Cancer
Neoplasms
Tumors
Vomiting
Adhesion
Deposits
Colorectal Cancer
Pain
Pelvic Neoplasms
Carcinoma
Focal Adhesions
Gastrostomy
Tumor
Hepatomegaly
Incidence
Colic
Tube
Drugs

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Statistics, Probability and Uncertainty
  • Applied Mathematics
  • Public Health, Environmental and Occupational Health
  • Neuropsychology and Physiological Psychology
  • Hematology

Cite this

Ripamonti, C., De Conno, F., Ventafridda, V., Rossi, B., & Baines, M. J. (1993). Management of bowel obstruction in advanced and terminal cancer patients. Annals of Oncology, 4(1), 15-21.

Management of bowel obstruction in advanced and terminal cancer patients. / Ripamonti, C.; De Conno, F.; Ventafridda, V.; Rossi, B.; Baines, M. J.

In: Annals of Oncology, Vol. 4, No. 1, 1993, p. 15-21.

Research output: Contribution to journalArticle

Ripamonti, C, De Conno, F, Ventafridda, V, Rossi, B & Baines, MJ 1993, 'Management of bowel obstruction in advanced and terminal cancer patients', Annals of Oncology, vol. 4, no. 1, pp. 15-21.
Ripamonti C, De Conno F, Ventafridda V, Rossi B, Baines MJ. Management of bowel obstruction in advanced and terminal cancer patients. Annals of Oncology. 1993;4(1):15-21.
Ripamonti, C. ; De Conno, F. ; Ventafridda, V. ; Rossi, B. ; Baines, M. J. / Management of bowel obstruction in advanced and terminal cancer patients. In: Annals of Oncology. 1993 ; Vol. 4, No. 1. pp. 15-21.
@article{3c5c9597c9024fb7b98fcec20a49fa53,
title = "Management of bowel obstruction in advanced and terminal cancer patients",
abstract = "Background: Bowel obstruction is a common and distressing outcome in patients with abdominal or pelvic cancer. Patients and methods: Patients may develop bowel obstruction at any time in their clinical history, with an incidence ranging from 5.5{\%} to 42{\%} in ovarian carcinoma and from 10{\%} to 28.4{\%} in colorectal cancer. The causes of the obstruction may be benign postoperative adhesions, a focal malignant or benign deposit, relapse or diffuse carcinomatosis. The symptoms which are almost always present are intestinal colic (reported in 72{\%}-76{\%} of patients), abdominal pain due to distension, hepatomegaly or tumor masses (in 92{\%} of patients) and vomiting (68{\%}-100{\%}) of cases. Conclusion: While surgery must remain the primary treatment for malignant obstruction, it is now recognised that there is a group of patients with advanced disease or poor general condition who are unfit for surgery and require alternative management to relieve distressing symptoms. A number of treatment options are now available for the patient with advanced cancer who develops intestinal obstruction. In this review of the literature, the indications for surgery will be examined, the use of nasogastric tube and percutaneous gastrostomy evaluated and the place of drugs for symptom control described.",
author = "C. Ripamonti and {De Conno}, F. and V. Ventafridda and B. Rossi and Baines, {M. J.}",
year = "1993",
language = "English",
volume = "4",
pages = "15--21",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "NLM (Medline)",
number = "1",

}

TY - JOUR

T1 - Management of bowel obstruction in advanced and terminal cancer patients

AU - Ripamonti, C.

AU - De Conno, F.

AU - Ventafridda, V.

AU - Rossi, B.

AU - Baines, M. J.

PY - 1993

Y1 - 1993

N2 - Background: Bowel obstruction is a common and distressing outcome in patients with abdominal or pelvic cancer. Patients and methods: Patients may develop bowel obstruction at any time in their clinical history, with an incidence ranging from 5.5% to 42% in ovarian carcinoma and from 10% to 28.4% in colorectal cancer. The causes of the obstruction may be benign postoperative adhesions, a focal malignant or benign deposit, relapse or diffuse carcinomatosis. The symptoms which are almost always present are intestinal colic (reported in 72%-76% of patients), abdominal pain due to distension, hepatomegaly or tumor masses (in 92% of patients) and vomiting (68%-100%) of cases. Conclusion: While surgery must remain the primary treatment for malignant obstruction, it is now recognised that there is a group of patients with advanced disease or poor general condition who are unfit for surgery and require alternative management to relieve distressing symptoms. A number of treatment options are now available for the patient with advanced cancer who develops intestinal obstruction. In this review of the literature, the indications for surgery will be examined, the use of nasogastric tube and percutaneous gastrostomy evaluated and the place of drugs for symptom control described.

AB - Background: Bowel obstruction is a common and distressing outcome in patients with abdominal or pelvic cancer. Patients and methods: Patients may develop bowel obstruction at any time in their clinical history, with an incidence ranging from 5.5% to 42% in ovarian carcinoma and from 10% to 28.4% in colorectal cancer. The causes of the obstruction may be benign postoperative adhesions, a focal malignant or benign deposit, relapse or diffuse carcinomatosis. The symptoms which are almost always present are intestinal colic (reported in 72%-76% of patients), abdominal pain due to distension, hepatomegaly or tumor masses (in 92% of patients) and vomiting (68%-100%) of cases. Conclusion: While surgery must remain the primary treatment for malignant obstruction, it is now recognised that there is a group of patients with advanced disease or poor general condition who are unfit for surgery and require alternative management to relieve distressing symptoms. A number of treatment options are now available for the patient with advanced cancer who develops intestinal obstruction. In this review of the literature, the indications for surgery will be examined, the use of nasogastric tube and percutaneous gastrostomy evaluated and the place of drugs for symptom control described.

UR - http://www.scopus.com/inward/record.url?scp=0027455706&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027455706&partnerID=8YFLogxK

M3 - Article

C2 - 8435356

AN - SCOPUS:0027455706

VL - 4

SP - 15

EP - 21

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 1

ER -